Page URL:

Gene therapy prevents brain disease symptoms in mice

7 July 2004
By BioNews
Appeared in BioNews 266

Performing gene therapy on mice can prevent the symptoms of a hereditary brain disease called spinocerebellar ataxia (SCA). This discovery, made by a research team from the University of Iowa, US, has prompted hopes of similar treatments for related brain disorders such as Huntington's and Alzheimer's. Unlike other gene therapy techniques that add a new gene to replace a faulty one, this method uses genetic material to turn off an existing faulty gene. The research, originally reported at a conference in June, will appear in the journal Nature Medicine in August.

The researchers treated mice with symptoms of SCA, an autosomal dominant neurodegenerative disease similar to Huntington's disease (HD). Autosomal dominant diseases are caused by a single copy of a faulty gene, inherited from an affected parent. In both HD and SCA, the faulty gene is responsible for production of an abnormal protein, which causes neurological damage. The researchers used a technique called RNAi (RNA interference), to 'silence' the faulty SCA1 gene. This approach uses short pieces of RNA (a close chemical relative of DNA) to trigger an immune response specific to the targeted gene, preventing production of the faulty protein.

The research team used a modified virus to transfer the RNA to the mice brain cells and, after six months of treatment, found that the mice had normal movement and co-ordination. Untreated mice developed movement problems and the researchers found evidence of brain cells being destroyed. The study represents a step forward in several areas, including targeting specific brain cells by using a particular virus. Beverly Davidson, who led the research team described the research as 'the first example of targeted gene silencing of a disease gene in the brains of live animals' and she expressed hopes that 'this approach may eventually be useful for human therapies'.

Thomas Tuschl, who was involved in the discovery of the primitive immune system, said the findings were remarkable, but cautioned that although 'they can prevent the disease if they start the treatment early, before symptoms were apparent, they have not shown whether treating a diseased 10-week-old animal would improve the symptoms'. Other commentators have pointed out that treating Huntington's disease in the same manner would require targeting multiple areas of the brain.

Combination Of Gene Therapy And Gene Silencing Prevents Neurodegenerative Disease
ScienceDaily |  5 July 2004
Gene silencing prevents hereditary brian disease in mice
New Scientist |  4 July 2004
Gene therapy holds hope of Alzheimer's cure
The Scotsman |  5 July 2004
28 September 2009 - by Dr Jay Stone 
Dr R. Scott Turner and his team of the Memory Disorders Program at Georgetown University, US, have begun recruiting patients to take part in a gene therapy trial, which hopes to test whether gene therapy using the nerve growth factor (NGF) gene could be used to slow the progression of Alzheimer's disease...
10 June 2006 - by Heidi Nicholl 
Research ranging from tackling muscle regeneration for injured athletes to a potential cure for haemophilia has been presented at the American Society of Gene Therapy meeting at Baltimore, Maryland. A team from the University of Pittsburgh has successfully used gene therapy techniques to promote accelerated skeletal muscle...
29 March 2006 - by BioNews 
US, Canadian and German researchers have used a novel gene therapy approach to reduce blood cholesterol levels in monkeys by more than 60 per cent. The research, published in the journal Nature, uses a technique called RNA interference (RNAi). The scientists - based at biotech firms Alnylam Pharmaceuticals and Protiva BioTherapeutics...
11 November 2004 - by BioNews 
German researchers have used a novel gene therapy approach to reduce blood cholesterol levels in mice. The research, published in the journal Nature, uses RNA - a close chemical relative of DNA. The scientists, based at biotech firm Alnylam Pharmaceuticals in Kulbach, describe their study as 'a historic step forward' in...
20 September 2004 - by BioNews 
The first clinical trial based on a promising new technology called RNA interference (RNAi) is set to begin in the US, to treat a progressive eye disorder. The researchers hope to test the safety of the technique for treating a disease called wet age-related macular degeneration (AMD). This condition, which...
7 June 2004 - by BioNews 
Researchers gathered at the American Society of Gene Therapy meeting in Minneapolis, Minnesota last week, to hear about new approaches and techniques in this promising area of medicine. A new type of gene therapy, involving injections of 'naked DNA' generated much excitement, when University of Wisconsin scientists presented their experiments...
17 March 2003 - by BioNews 
A new study by US researchers suggests that gene therapy could be used to treat Huntington's disease (HD), a severe inherited brain disorder. Scientists at the University of Iowa have used a new technique to 'silence' the gene that makes the protein involved in HD in laboratory-grown human cells. 'When...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.